DS MED LLC - 17 May 2022 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
10%+ Owner
Signature
/s/ Paul T. Lehr, attorney-in-fact
Issuer symbol
LGVN
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 18:00:41 UTC
Previous filing
15 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Other $0 -7,024,208 -100% $0.000000* 0 17 May 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

DS MED LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2 Shares distributed on a pro rated basis to members of DS Med, LLC, for no consideration.